Collegium Pharmaceutical, Inc. COLL Jornay PM — Finite-Lived Intangible Assets, Net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — finite-lived intangible assets, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net?
- Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — finite-lived intangible assets, net of $502.97M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net changed year-over-year?
- Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net decreased by 14.3% year-over-year, from $586.8M to $502.97M.
- What does jornay PM — finite-lived intangible assets, net mean?
- This metric reflects the current book value of a specific product's finite-lived intangible assets after deducting accumulated amortization. It provides insight into the remaining unamortized investment value of the product's intellectual property.